proposed site specific settlement land

site-specific settlement land

site directed mutagenesis | site specific mutagenesis

site-specific analysis

Definition: The main feature is a specific and significant impairment in the development of reading skills that is not solely accounted for by mental age, visual acuity problems, or inadequate schooling. Reading comprehension skill, reading word recognition, oral reading skill, and performance of tasks requiring reading may all be affected. Spelling difficulties are frequently associated with specific reading disorder and often remain into adolescence even after some progress in reading has been made. Specific developmental disorders ...[+++]of reading are commonly preceded by a history of disorders in speech or language development. Associated emotional and behavioural disturbances are common during the school age period. | Backward reading Developmental dyslexia Specific reading retardation

site specific mutagenesis

Definition: The main feature is a specific and significant impairment in the development of spelling skills in the absence of a history of specific reading disorder, which is not solely accounted for by low mental age, visual acuity problems, or inadequate schooling. The ability to spell orally and to write out words correctly are both affected. | Specific spelling retardation (without reading disorder)

legatee by particular title | particular legatee | specific legatee | specific devisee

Definition: Symptoms are presented by the patient as if they were due to a physical disorder of a system or organ that is largely or completely under autonomic innervation and control, i.e. the cardiovascular, gastrointestinal, respiratory and urogenital systems. The symptoms are usually of two types, neither of which indicates a physical disorder of the organ or system concerned. First, there are complaints based upon objective signs of autonomic arousal, such as palpitations, sweating, flushing, tremor, and expression of fear and distress about the possibility of a physical disorder. Second, there are subjective complaint ...[+++]s of a nonspecific or changing nature such as fleeting aches and pains, sensations of burning, heaviness, tightness, and feelings of being bloated or distended, which are referred by the patient to a specific organ or system. | Cardiac neurosis Da Costa's syndrome Gastric neurosis Neurocirculatory asthenia Psychogenic forms of:aerophagy | cough | diarrhoea | dyspepsia | dysuria | flatulence | hiccough | hyperventilation | increased frequency of micturition | irritable bowel syndrome | pylorospasm

14. Highlights the importance of improving accessibility to cultural heritage sites and cultural education, taking into account, in particular, the specific needs of people with disabilities when constructing, renovating or extending tourist attractions; notes that, in this context, innovative projects, tools and products to facilitate autonomous access for persons with impaired mobility should be promoted at European level; bears in mind that information and booking technologies should be easily accessible for those persons; under ...[+++]lines the enormous progress made thanks to the application and use of new digital technologies for giving universal access to paintings, buildings, and cultural sites; suggests to the Commission and the Member States that they examine different possibilities of launching projects and funds to enable the younger population and – in the context of demographic change – older persons, as well as people with special needs, low-income families and other vulnerable citizens, to visit the Member States’ cultural destinations;

So I can see a lot of reasons why we should be moving forward with this bill and getting Parks Canada to set up two, three, or four sites—and probably that's all it will be for quite a while—but if we can get those sites, then we'll move ahead provincially with the marine protected areas and in other more specific sites of conservation interest.

It includes not only the parts of the website concerned offering a specific service, but the entire website related to it.

Question No. 53 Ms. Kirsty Duncan: With respect to the chronic cerebrospinal venous insufficiency (CCSVI) clinical trial being undertaken by Dr. Traboulse: (a) what milestones are reportable to the government, (i) on what date(s) is reporting expected to occur, (ii) how will this information be communicated to patients, the medical community, and the general public; (b) on what date did each of the trial sites pass ethical review; (c) on what date did recruitment of patients begin for each of the trial sites; (d) how many patients with multiple sclerosis (MS) are being recruited for each site, and how is consistency in diagnosis and t ...[+++]reatment being ensured across sites; (e) who is performing the diagnoses for CCSVI for each site, (i) how is the diagnosis being performed, including, but not limited to, ultrasound and venogram, (ii) how many diagnoses has each person undertaking the diagnosis at each site performed prior to the study, and by whom was each person trained; (f) who is performing the procedures for each site, (i) how is the procedure being performed, including, but not limited to, anesthetic, balloon size, (ii) how many procedures has each person undertaking the procedure at each site performed prior to the study, and by whom was each person trained; (g) what are the selection criteria for the trial, including, but not limited to, type of MS, Expanded Disability Status Scale (EDSS) score, venous abnormality/malformed valve/stenosis, mobility, (i) how do these criteria compare with the international literature, (ii) with how many international studies to date will the selection criteria be analytically comparable; (h) if both progressive and relapsing-remitting forms of MS are to be examined in the trial, how will statistical significance be ensured given that 50 of 100 patients will undergo a “sham” procedure, 25 patients will have a progressive form of the disease, and 25 will have a relapsing-remitting form of the disease, and will people with bo ...